Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congressional Leaders To Consider “Emergency Legislation” In Wake Of Heparin Safety Scare

This article was originally published in PharmAsia News

Executive Summary

Congressional leaders have ratcheted up the heat on U.S. FDA and Baxter Healthcare over their handling of the heparin safety scare, alleging that the agency has abandoned its policy to conduct preapproval inspections of API suppliers and saying they would consider introducing "emergency legislation" to mandate such inspections
Advertisement

Related Content

FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
HHS Secretary Leavitt Calls For “Explicit Extraterritorial Jurisdiction” For U.S. FDA
HHS Secretary Leavitt Calls For “Explicit Extraterritorial Jurisdiction” For U.S. FDA
With Overstretched FDA, Companies Advised To Conduct Their Own Foreign Inspections – Former FDA Chief Counsel
With Overstretched FDA, Companies Advised To Conduct Their Own Foreign Inspections – Former FDA Chief Counsel
U.S. FDA Inspected “Wrong” Heparin API Manufacturer – Compliance Official
Heparin Investigation Highlights Foreign Inspection Gap – Former FDA Officials
Advertisement
UsernamePublicRestriction

Register

SC067721

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel